SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Healthcare >

VG Life Sciences Inc. (VGLS)

VGLS RSS Feed
Add VGLS Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/25/2017 10:06:55 AM - Followers: 82 - Board type: Free - Posts Today: 2

Viral Genetics Inc.

2290 Huntington Dr. Suite 100 San Marino, CA, 91108

Phone: 626-334-5310

http://www.vglifesciences.com
info@vglifesciences.com

Developing a pipeline of transformative therapies to combat cancer, infectious diseases and autoimmune diseases caused by chronic inflammation

 

VG Life Sciences’ research deploys two technology platforms in the development of transformative therapies to combat drug-sensitive and multi drug-resistant cancers, infectious diseases and autoimmune diseases caused by chronic inflammation. As patient advocates, we are driven by our passion to fulfill an unmet need to treat these pernicious and deadly diseases.

Our scientific team, led by a foremost expert in chronic inflammation and autoimmune diseases, collaborates with thought leaders around the globe to advance novel treatments that will save and improve millions of lives. Our management, advisers and collaborators, who have had impressive success in business, drug development and the pharmaceutical industry, are contributing broad expertise and support to helping us accomplish our mission.

Our patent-pending cancer therapy, a combination of two FDA-approved drugs, has produced promising results in early-stage clinical trials during which prolonged periods of disease stabilization were shown in patients with metastatic ovarian cancer, triple-negative breast cancer and metastatic lung cancer. We believe our drug disrupts the cells’ metabolic ability to acquire energy, making them more susceptible to cancer-killing agents, and more visible and vulnerable to the body’s own immune system.

VG1177 deploys a patented, synthesized peptide that uses its superior binding abilities to eliminate the unwanted CLIP (Class II-associated invariant chain peptide) that is displayed on specific B cells, leading to chronic inflammation. In essence, VG1177 knocks the unwanted CLIP off the cell, halting the chronic inflammatory state that plays a major role in numerous autoimmune diseases. In our pre-clinical research, VG1177 has shown effectiveness against hypertension, traumatic brain injury and preeclampsia. Our primary focus is to rapidly advance this drug candidate into pre-clinical studies and clinical trials.


================================================================

VGLS MANAGEMENT TEAM:

http://www.vglifesciences.com/our-team/

VGLS PRESS RELEASES:

http://www.vglifesciences.com/investors/press-releases.php

VGLS SHARE STRUCTURE AS OF OCTOBER 31st, 2015

Outstanding Shares

  92,262,471 a/o October 31st, 2015

Authorized Shares

  170,000,000 a/o October 31st, 2015

Float(shares)

  52,246,172 a/o October 31st, 2015


Chart:

SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
VGLS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#3300   http://s1.q4cdn.com/460208960/files/doc_coverage/Biotech%20-%20Grant%20Zeng/VRAL ALLEYCATINHEET 09/25/17 10:06:55 AM
#3299   http://dermatologytimes.modernmedicine.com/dermatology-times/news/clinical/clini ALLEYCATINHEET 09/25/17 10:05:32 AM
#3298   http://www.mdjunction.com/forums/lyme-disease-support-forums/general-support/141 ALLEYCATINHEET 09/24/17 04:31:42 PM
#3297   https://www.ncbi.nlm.nih.gov/m/pubmed/28642294/ ALLEYCATINHEET 09/24/17 04:58:28 AM
#3296   http://www.clinsci.org/content/early/2017/06/22/CS20171008 ALLEYCATINHEET 09/24/17 04:56:51 AM
#3295   Epilepsy therapy is in the works too https://www.cureepilepsy.org/our-research ALLEYCATINHEET 09/23/17 02:38:36 AM
#3294   VGLS is severely delinquent in filing the company's Renee 09/19/17 06:47:22 PM
#3293   Thank you partner I'm so excited for the ALLEYCATINHEET 09/18/17 08:55:24 AM
#3292   Jack@Jbecpa.com. Does not matter on case Beaumont 09/18/17 08:44:06 AM
#3291   What's your email ALLEYCATINHEET 09/17/17 10:52:10 PM
#3290   This is fascinating, send me your email, Beaumont 09/17/17 07:23:07 PM
#3289   Bayer/ Onyx Pharmaceutical com- pound comes of patent ALLEYCATINHEET 09/17/17 02:28:49 PM
#3288   Don't believe institutional would be involved for long Beaumont 09/17/17 12:27:40 PM
#3287   Beaumont! you hit the nail right on the ALLEYCATINHEET 09/17/17 11:44:50 AM
#3286   I have doubled my position since the first Beaumont 09/17/17 08:14:55 AM
#3285   Look I have been in this a long Beaumont 09/17/17 07:34:15 AM
#3284   Cap trust only 34 shares, why so few?? Beaumont 09/17/17 07:12:02 AM
#3283   http://media.wix.com/ugd/fa4a39_5c77c16629d04434a1668972cbc9a981.pdf ALLEYCATINHEET 09/17/17 06:50:28 AM
#3282   http://www.nasdaq.com/quotes/institutional-portfolio/captrust-financial-advisors ALLEYCATINHEET 09/17/17 05:49:07 AM
#3281   Captrust Financial Advisors are on board too ALLEYCATINHEET 09/17/17 02:05:10 AM
#3280   W.B. Has expanded their presence in biopharm. Beaumont 09/16/17 10:36:37 PM
#3279   So AC, like that large investment banker bought Beaumont 09/15/17 03:19:08 PM
#3278   From The Economist Espresso: Networking narcos: canna-business https://espresso. ALLEYCATINHEET 09/13/17 01:40:36 PM
#3277   Other institutions will follow ALLEYCATINHEET 09/12/17 05:35:07 PM
#3276   Just beginning baby ALLEYCATINHEET 09/12/17 05:34:46 PM
#3275   https://fintel.io/i/blair-william-co-il ALLEYCATINHEET 09/12/17 05:34:25 PM
#3274   Buy your shares too ALLEYCATINHEET 09/11/17 11:57:32 AM
#3273   William Blair & Co. is buying something is happening ALLEYCATINHEET 09/11/17 11:57:12 AM
#3272   http://repro.tamu.edu/files/2012/05/IFRB-Newsletter-2016.pdf ALLEYCATINHEET 09/09/17 10:07:33 AM
#3271   http://www.clinsci.org/content/early/2017/06/22/CS20171008 ALLEYCATINHEET 09/09/17 09:59:03 AM
#3270   https://www.davidchristensenlaw.com/immune-system-may-harm-traumatic-brain-injur ALLEYCATINHEET 09/09/17 09:53:47 AM
#3269   http://sagaciousresearch.com/blog/vg-life-sciences-peptide-vg1177-awarded-us-pat ALLEYCATINHEET 09/09/17 09:50:27 AM
#3268   http://bciq.biocentury.com/products/vg1177 ALLEYCATINHEET 09/09/17 09:49:10 AM
#3267   http://m.fasebj.org/content/30/1_Supplement/966.5?related-urls=yes&legid=fasebj% ALLEYCATINHEET 09/09/17 09:47:51 AM
#3266   Interest picking up ALLEYCATINHEET 09/09/17 09:25:48 AM
#3265   http://www.nasdaq.com/symbol/vgls/institutional-holdings ALLEYCATINHEET 09/09/17 09:24:56 AM
#3264   https://hiramherald.com/pounding-the-pavement-on-shares-of-vg-life-sciences-inc- ALLEYCATINHEET 08/31/17 07:18:43 AM
#3263   Good evidence on tumor treatment; mentioned in newsletter Beaumont 08/24/17 12:23:05 PM
#3262   Drug combination indicates more effective solid tumor cancer ALLEYCATINHEET 08/24/17 06:02:57 AM
#3261   http://stockreads.com/Stock-Newsletter.aspx?id=83993 ALLEYCATINHEET 08/24/17 05:55:05 AM
#3260   http://nlrnews.com/todays-volume-leaders-vg-life-sciences-inc-vgls/199228/ ALLEYCATINHEET 08/22/17 11:39:45 AM
#3259   You must be selling Beaumont 08/08/17 03:19:09 PM
#3258   Buy ALLEYCATINHEET 08/08/17 12:11:05 PM
#3257   give us some real news Beaumont 07/28/17 09:35:32 AM
#3256   https://jctynews.com/needle-action-activity-spotted-in-vg-life-sciences-inc-vgls ALLEYCATINHEET 07/27/17 05:40:40 PM
#3255   90k @ 1.2C on ask, no one buying Beaumont 07/26/17 11:55:23 AM
#3254   Make that 1k ALLEYCATINHEET 07/26/17 11:05:33 AM
#3253   Only 3k on the ask what's going on ALLEYCATINHEET 07/26/17 11:02:52 AM
#3252   https://buckeyebusinessreview.com/2017/07/24/vg-life-sciences-inc-vgls-price-pul ALLEYCATINHEET 07/25/17 10:33:10 PM
#3251   only 10-20% of these cos make it. Beaumont 07/25/17 10:32:22 AM
PostSubject